TY - JOUR
T1 - Mena regulates nesprin-2 to control actin– 1 nuclear lamina associations, trans-nuclear 2 membrane signalling and gene expression
AU - Li Mow Chee, Frederic
AU - Beernaert Dominguez, Bruno
AU - Griffith, Billie
AU - Loftus, Alex
AU - Kumar, Yatendra
AU - Wills, Jimi
AU - Lee, Martin
AU - Valli, Jessica
AU - Wheeler, Ann P
AU - Armstrong, J. Douglas
AU - Parsons, Maddy
AU - Leigh, Irene M.
AU - Proby, Charlotte
AU - von Kriegsheim, Alexander
AU - Bickmore, Wendy A
AU - Frame, Margaret C
AU - Byron, Adam
N1 - Funding Information:
We are grateful to Val Brunton, Francesca Di Modugno, Noor Gammoh, Frank Gertler and Eric Schirmer for reagents. We thank the University of Edinburgh Institute of Genetics and Cancer (IGC) Mass Spectrometry Facility for LC-MS/MS data acquisition; Alison Munro and the IGC Host and Tumour Profiling Unit Microarray Services for multiplexed gene expression analysis; Lizzie Freyer and the IGC Flow Cytometry Facility for flow cytometry analysis; Stephen Brown, Jeffrey Joseph and the IGC DNA Sequencing Facility for DNA sequencing; Amy Davies, Laura Murphy, Matt Pearson and the IGC Advanced Imaging Resource and Edinburgh Super Resolution Imaging Consortium for assistance with microscopy and image analysis; Richard Clark and the Edinburgh Clinical Research Facility for next-generation sequencing; Ainara Cabodevilla for assistance with lentiviral transduction; Laura Gómez-Cuadrado for assistance with RT-qPCR; Noor Gammoh for discussions and assistance with CRISPR/Cas9; Colin McLean for discussions and assistance with network analysis; Katerina Petelova for discussions and exploratory data analysis; Val Brunton, Gareth Inman, Roza Masalmeh, Bryan Serrels and Andy Sims for discussions. The work was funded by Cancer Research UK (grants C157/A15703 and C157/A24837 to M.C.F.). Development of the cSCC cell lines was funded by Cancer Research UK (grant A13044) and the European Research Council (grant 250170). W.A.B. was funded by a Medical Research Council University Unit grant (grant MC_UU_00007/2). M.P. was funded by the Medical Research Council (grant MR/R008264/1). J.D.A. was funded by a European Union Horizon 2020 Framework Programme for Research and Innovation (grant 945539; Human Brain Project SGA3). Y.K. was funded by a Wellcome Trust Discovery Award (grant 217120/Z/19/Z to W.A.B.). The STED system at the Edinburgh Super Resolution Imaging Consortium was supported by the Wellcome Trust (grant 208345/Z/17/Z). The work made use of the resources provided by the Edinburgh Compute and Data Facility (ECDF), University of Edinburgh [https://www.ecdf.ed.ac.uk]. For the purpose of open access, the authors have applied a CC-BY public copyright licence to any author accepted manuscript version arising from this submission.
Funding Information:
We are grateful to Val Brunton, Francesca Di Modugno, Noor Gammoh, Frank Gertler and Eric Schirmer for reagents. We thank the University of Edinburgh Institute of Genetics and Cancer (IGC) Mass Spectrometry Facility for LC-MS/MS data acquisition; Alison Munro and the IGC Host and Tumour Profiling Unit Microarray Services for multiplexed gene expression analysis; Lizzie Freyer and the IGC Flow Cytometry Facility for flow cytometry analysis; Stephen Brown, Jeffrey Joseph and the IGC DNA Sequencing Facility for DNA sequencing; Amy Davies, Laura Murphy, Matt Pearson and the IGC Advanced Imaging Resource and Edinburgh Super Resolution Imaging Consortium for assistance with microscopy and image analysis; Richard Clark and the Edinburgh Clinical Research Facility for next-generation sequencing; Ainara Cabodevilla for assistance with lentiviral transduction; Laura Gómez-Cuadrado for assistance with RT-qPCR; Noor Gammoh for discussions and assistance with CRISPR/Cas9; Colin McLean for discussions and assistance with network analysis; Katerina Petelova for discussions and exploratory data analysis; Val Brunton, Gareth Inman, Roza Masalmeh, Bryan Serrels and Andy Sims for discussions. The work was funded by Cancer Research UK (grants C157/A15703 and C157/A24837 to M.C.F.). Development of the cSCC cell lines was funded by Cancer Research UK (grant A13044) and the European Research Council (grant 250170). W.A.B. was funded by a Medical Research Council University Unit grant (grant MC_UU_00007/2). M.P. was funded by the Medical Research Council (grant MR/R008264/1). J.D.A. was funded by a European Union Horizon 2020 Framework Programme for Research and Innovation (grant 945539; Human Brain Project SGA3). Y.K. was funded by a Wellcome Trust Discovery Award (grant 217120/Z/19/Z to W.A.B.). The STED system at the Edinburgh Super Resolution Imaging Consortium was supported by the Wellcome Trust (grant 208345/Z/17/Z). The work made use of the resources provided by the Edinburgh Compute and Data Facility (ECDF), University of Edinburgh [ https://www.ecdf.ed.ac.uk ]. For the purpose of open access, the authors have applied a CC-BY public copyright licence to any author accepted manuscript version arising from this submission.
Publisher Copyright:
© 2023, The Author(s).
PY - 2023/3/23
Y1 - 2023/3/23
N2 - Interactions between cells and the extracellular matrix, mediated by integrin adhesion complexes, play key roles in fundamental cellular processes, including the sensing and transduction of mechanical cues. Here, we investigate systems-level changes in the integrin adhesome in patient-derived cutaneous squamous cell carcinoma cells and identify the actin regulatory protein Mena as a key node in the adhesion complex network. Mena is connected within a subnetwork of actin-binding proteins to the LINC complex component nesprin-2, with which it interacts and co-localises at the nuclear envelope. Moreover, Mena potentiates the interactions of nesprin-2 with the actin cytoskeleton and the nuclear lamina. CRISPR40 mediated Mena depletion causes altered nuclear morphology, reduces tyrosine phosphorylation of the nuclear membrane protein emerin and down regulates expression of the immunomodulatory gene PTX3 via the recruitment of its enhancer to the nuclear periphery. We uncover an unexpected role for Mena at the nuclear membrane, where it controls nuclear architecture, chromatin repositioning and gene expression. Our findings identify an adhesion protein that regulates gene transcription via direct signalling across the nuclear envelope.
AB - Interactions between cells and the extracellular matrix, mediated by integrin adhesion complexes, play key roles in fundamental cellular processes, including the sensing and transduction of mechanical cues. Here, we investigate systems-level changes in the integrin adhesome in patient-derived cutaneous squamous cell carcinoma cells and identify the actin regulatory protein Mena as a key node in the adhesion complex network. Mena is connected within a subnetwork of actin-binding proteins to the LINC complex component nesprin-2, with which it interacts and co-localises at the nuclear envelope. Moreover, Mena potentiates the interactions of nesprin-2 with the actin cytoskeleton and the nuclear lamina. CRISPR40 mediated Mena depletion causes altered nuclear morphology, reduces tyrosine phosphorylation of the nuclear membrane protein emerin and down regulates expression of the immunomodulatory gene PTX3 via the recruitment of its enhancer to the nuclear periphery. We uncover an unexpected role for Mena at the nuclear membrane, where it controls nuclear architecture, chromatin repositioning and gene expression. Our findings identify an adhesion protein that regulates gene transcription via direct signalling across the nuclear envelope.
U2 - 10.1038/s41467-023-37021-x
DO - 10.1038/s41467-023-37021-x
M3 - Article
SN - 2041-1723
JO - Nature Communications
JF - Nature Communications
ER -